Swati Bhayana Leads Breakthrough Pediatric Sickle Cell Cure in India
Swati Bhayana, Consultant at Fortis Healthcare, shared a post by Biomall.in on LinkedIn:
”Gratitude to the amazing team of doctors, nurses, hospital management who supported endlessly for the dream
– We are the force.”
Quoting Biomall.in’s post:
”Hope for Sickle Cell: A Breakthrough in India’s Pediatric Care
India marks a major milestone in the fight against Sickle Cell Disease (SCD) with a decade-long clinical study demonstrating the transformative potential of pediatric stem-cell transplantation.
Led by Dr. SWATI BHAYANA, a leading pediatric hematologist at Fortis Healthcare Gurugram, the team has reported remarkable outcomes:~87% overall survival rate among children undergoing stem-cell transplant 96% survival when the donor is a matched sibling, Significant reduction in long-term complications, and improved quality of life
This achievement brings India closer to offering globally benchmarked curative therapy, especially critical for high-burden tribal and underserved regions. It underscores the power of clinical innovation, strong donor-matching programs, and advanced transplant care in reshaping SCD management.
Read the full article here.”
Title: Indian Healthcare Achieves Global Standards in Pediatric SCD Cure
Stay informed with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy